Page last updated: 2024-11-04

temozolomide and Aura

temozolomide has been researched along with Aura in 9 studies

Research Excerpts

ExcerptRelevanceReference
"To confirm the hypothesis suggested above, a combined analysis of survival association of antiepileptic drug use at the start of chemoradiotherapy with temozolomide was performed in the pooled patient cohort (n = 1,869) of four contemporary randomized clinical trials in newly diagnosed glioblastoma: AVAGlio (Avastin in Glioblastoma; NCT00943826), CENTRIC (Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status; NCT00689221), CORE (Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status; NCT00813943), and Radiation Therapy Oncology Group 0825 (NCT00884741)."7.83Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. ( Chinot, O; Cloughesy, T; Gilbert, MR; Gorlia, T; Happold, C; Hegi, M; Mehta, MP; Nabors, LB; Perry, JR; Pugh, SL; Reardon, DA; Roth, P; Stupp, R; Weller, M; Wick, W, 2016)
"Temozolomide treatment did not affect TPM plasma concentrations in chronically treated patients."6.73Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. ( Albani, F; Baruzzi, A; Contin, M; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Zarabla, A, 2008)
" Temozolomide is a novel second-generation alkylating agent that has shown efficacy for the treatment of high-grade gliomas."4.84[Glioma therapy up-date]. ( Dalmau, J; de la Fuente, BP; Rosenfeld, M, 2007)
" The place of chemotherapy is growing not only for anaplastic oligodendrogliomas, more chemosensitive (particularly when they harbor 1p19q codeletions), but also for glioblastomas patients, which have been shown to benefit from radiotherapy plus concomitant and adjuvant temozolomide."4.83[Pattern of care of high-grade gliomas]. ( Laigle-Donadey, F; Sanson, M, 2006)
"To confirm the hypothesis suggested above, a combined analysis of survival association of antiepileptic drug use at the start of chemoradiotherapy with temozolomide was performed in the pooled patient cohort (n = 1,869) of four contemporary randomized clinical trials in newly diagnosed glioblastoma: AVAGlio (Avastin in Glioblastoma; NCT00943826), CENTRIC (Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status; NCT00689221), CORE (Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status; NCT00813943), and Radiation Therapy Oncology Group 0825 (NCT00884741)."3.83Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. ( Chinot, O; Cloughesy, T; Gilbert, MR; Gorlia, T; Happold, C; Hegi, M; Mehta, MP; Nabors, LB; Perry, JR; Pugh, SL; Reardon, DA; Roth, P; Stupp, R; Weller, M; Wick, W, 2016)
"Temozolomide treatment did not affect TPM plasma concentrations in chronically treated patients."2.73Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. ( Albani, F; Baruzzi, A; Contin, M; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Zarabla, A, 2008)
"Thrombocytopenia was operationalized as a continuous platelet count and a dichotomic variable (cut-off <100."1.38Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy. ( Blasco, J; Bruna, J; Gil, M; Graus, F; Pineda, E; Simó, M; Velasco, R; Verger, E, 2012)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Li, F1
Zhang, Y1
Wang, N1
Song, C1
Gao, Y1
Diao, X1
Zhang, H1
Loftus, JC1
Dhruv, H1
Tuncali, S1
Kloss, J1
Yang, Z1
Schumacher, CA1
Cao, B1
Williams, BO1
Eschbacher, JM1
Ross, JT1
Tran, NL1
Happold, C1
Gorlia, T1
Chinot, O1
Gilbert, MR1
Nabors, LB1
Wick, W1
Pugh, SL1
Hegi, M1
Cloughesy, T1
Roth, P1
Reardon, DA1
Perry, JR1
Mehta, MP1
Stupp, R1
Weller, M1
Maschio, M2
Albani, F1
Jandolo, B1
Zarabla, A1
Contin, M1
Dinapoli, L2
Fabi, A1
Pace, A1
Baruzzi, A1
Vidiri, A1
Muti, P1
Simó, M1
Velasco, R1
Graus, F1
Verger, E1
Gil, M1
Pineda, E1
Blasco, J1
Bruna, J1
Ngo, L1
Nei, M1
Glass, J1
Laigle-Donadey, F1
Sanson, M1
de la Fuente, BP1
Dalmau, J1
Rosenfeld, M1

Reviews

2 reviews available for temozolomide and Aura

ArticleYear
[Pattern of care of high-grade gliomas].
    La Revue du praticien, 2006, Oct-31, Volume: 56, Issue:16

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anticonvulsants; Antineoplastic Agents, Alkylatin

2006
[Glioma therapy up-date].
    Neurologia (Barcelona, Spain), 2007, Volume: 22, Issue:3

    Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemothe

2007

Trials

1 trial available for temozolomide and Aura

ArticleYear
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:2

    Topics: Adult; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carbamazepine; Dacarbazi

2008

Other Studies

6 other studies available for temozolomide and Aura

ArticleYear
Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
    World neurosurgery, 2020, Volume: 138

    Topics: Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Contrast Me

2020
TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Cell Line, Tumor; Cell Movement; Cell Prolife

2013
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Mar-01, Volume: 34, Issue:7

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemor

2016
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.
    Journal of neurology, 2010, Volume: 257, Issue:11

    Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Combined Modality Therapy; C

2010
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.
    Journal of neuro-oncology, 2012, Volume: 108, Issue:3

    Topics: Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine;

2012
Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
    Epilepsia, 2006, Volume: 47, Issue:7

    Topics: Adult; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Comorbidity; Dacarbazine

2006